Announcements Trials
Browse Landscape

Phase

Phase NA 17Phase 2 6Phase 3 2Phase EARLY_PHASE1 1Phase 2/3 1Phase 1/2 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 8Plasma cell 5Other hematologic neoplasm 4Lymphoid 4Thoracic 3Myeloid 3Gastrointestinal 3Dermatologic 3CNS 3Sarcoma 2Other neoplasm 2Other 2Gynecologic 2Genitourinary 2Classical hematology 1

Conditions

Prostatic Neoplasms 505Urinary Bladder Neoplasms 139Carcinoma, Renal Cell 117Neoplasms 67Kidney Neoplasms 53Non-Muscle Invasive Bladder Neoplasms 43Neoplasm Metastasis 38Carcinoma, Transitional Cell 38Breast Neoplasms 30Testicular Neoplasms 28Recurrence 20Wilms Tumor 18Parkinson Disease 4, Autosomal Dominant Lewy Body 14Pain 13Ovarian Neoplasms 13Urologic Neoplasms 12Testicular Germ Cell Tumor 12Teratoma 12Seminoma 12Multiple Myeloma 12Burkitt Lymphoma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma, Large B-Cell, Diffuse 11Carcinoma, Ovarian Epithelial 11Carcinoma 11Urogenital Neoplasms 10Neuroblastoma 10Lymphoma, Non-Hodgkin 10Lymphoma, Mantle-Cell 10Lymphoma, Large-Cell, Immunoblastic 10

Interventions

Epoetin Alfa 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Fatigue × Genitourinary × Clear all
NCT00060398 2023-06-15

Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer

Eastern Cooperative Oncology Group

Phase 3 Completed
282 enrolled
Classical hematologyGenitourinary

Anemia, Fatigue, Prostatic Neoplasms

NCT00869011 2009-12-23

Exercise for Patients With Renal Cell Cancer Receiving Sunitinib

Charite University, Berlin, Germany

Phase 3 Unknown
70 enrolled
Genitourinary

Carcinoma, Renal Cell, Fatigue, Motor Activity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡